Dr. Haley Abivardi, DMDCEO & Co-Founder

Dr. Haley Abivardi is Chief Executive Officer and Co-Founder of vVARDIS, a Swiss high-growth healthcare company pioneering biomimetic, non-invasive dental technologies for caries management. Since co-founding vVARDIS in 2020 with her sister, Dr. Goly Abivardi, Haley has driven the company’s growth with an entrepreneurial vision, advancing vVARDIS’ mission to expand access to innovative dental care solutions and address tooth decay, the world’s most prevalent non-communicable disease and the number one chronic disease among children.

Haley earned her Doctor of Dental Medicine (DMD) from the University of Zurich, where she also completed her dissertation in 1998. She began her career co-leading a public pediatric dental clinic in Switzerland, providing dental care to thousands of children, particularly from underserved communities. In 2003, she and her sister founded Swiss Smile, Switzerland’s first dental service organization (DSO) and Europe’s first fear-free dental clinic groups, setting new benchmarks for accessible, patient-friendly oral healthcare. In 2007, Drs. Abivardi launched a global brand offering a line of premium oral care products. The same year they received several national and international awards, including the “Businesswoman of the Year Award” and the “Private Dentistry Awards,” among others. Haley also co-ran a dental hygienist school, supporting clinical studies and innovation in dentistry.

With more than two decades of experience as a dentist, entrepreneur, and advocate for non-invasive, patient-centric dental care, acknowledging the connection between oral health and overall health, Haley is recognized internationally as a leader and innovator in oral health. Under her leadership, vVARDIS is expanding the development and commercialization of Curodont™, its proprietary treatment for early-stage tooth decay that enables intervention without drilling and preserves natural tooth structure, which is backed by over 25 years of research and over 200 studies. Haley is a frequent speaker at international healthcare and business forums, where she addresses dental innovation, entrepreneurship, and the future of early-intervention care.

Haley is based in Zug, Switzerland.

Haley Abivardi

Dr. Goly Abivardi, DMD
CEO and Co-founder

Dr. Goly Abivardi is Chief Executive Officer and Co-Founder of vVARDIS, a Swiss high-growth healthcare company leading innovation in biomimetic and non-invasive technologies for caries management. Since co-founding vVARDIS in 2020 with her sister, Dr. Haley Abivardi, Goly has played a pivotal role in building the company’s global presence and advancing its reputation for scientific excellence. With her forward-thinking leadership she is shaping vVARDIS vision to elevate oral health as a foundation for overall health.

Goly earned her Doctor of Dental Medicine (DMD, Dr. Med. Dent.) from the University of Zurich and completed her dissertation in 2001. She began her career co-leading a public pediatric dental clinic in Switzerland, focused on preventive care for children, particularly from underserved communities. In 2003, she and her sister co-founded Swiss Smile, Switzerland’s first dental service organization (DSO) and Europe’s first fear-free dental clinic groups, introducing a new model of care that emphasized accessibility, comfort, and holistic well-being. In 2007, Drs. Abivardi launched a global brand offering a line of premium oral care products. In 2007, they received several national and international awards including the “Businesswoman of the Year Award” and the “Private Dentistry Awards,” among others. Goly also co-led a dental hygienist school, where they ran clinical studies and research to support advancement in dental technology.

With more than two decades of experience as a dentist, entrepreneur, and advocate for non-invasive, patient-centric dental care, acknowledging the connection between oral health and overall health, Goly is recognized internationally as a leader and innovator in oral health. Under her leadership, vVARDIS is expanding the development and commercialization of Curodont™, its proprietary treatment for early-stage tooth decay that and enables intervention without drilling and preserves natural tooth structure, which is backed by over 25 years of research and over 200 studies. Goly is a frequent speaker at international healthcare and business forums, where she addresses dental innovation, entrepreneurship, and the future of non-invasive care.

Goly is based in Zurich, Switzerland.

Goly Abivardi